PlainRecalls
FDA Drug Moderate Class II Terminated

Zonisamide Capsules USP, 100 mg, 90-count bottle, Rx Only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 61919-775-90

Reported: June 1, 2022 Initiated: May 13, 2022 #D-0888-2022

Product Description

Zonisamide Capsules USP, 100 mg, 90-count bottle, Rx Only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 61919-775-90

Reason for Recall

CGMP Deviations: Gaps in the quality system in the Quality Control microbiology laboratory.

Details

Recalling Firm
Direct Rx
Units Affected
16 bottles
Distribution
Nationwide to the U.S. market
Location
Dawsonville, GA

Frequently Asked Questions

What product was recalled?
Zonisamide Capsules USP, 100 mg, 90-count bottle, Rx Only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 61919-775-90. Recalled by Direct Rx. Units affected: 16 bottles.
Why was this product recalled?
CGMP Deviations: Gaps in the quality system in the Quality Control microbiology laboratory.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 1, 2022. Severity: Moderate. Recall number: D-0888-2022.